ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO234

The Loss of Heparin Sulphate Editing Enzyme Sulf1 Reduces VEGF Signaling and Enhances Endothelial Glomerular Injury and Albuminuria

Session Information

  • Glomerular: Cell Biology
    November 04, 2017 | Location: Hall H, Morial Convention Center
    Abstract Time: 10:00 AM - 10:00 AM

Category: Glomerular

  • 1003 Glomerular: Cell Biology

Authors

  • Masseli, Anna Katharina, Hannover Medical School, Hannover, Germany
  • Schroder, Patricia Ann, Mount Desert Island Biological Laboratory, Salisbury Cove, Maine, United States
  • Beverly-Staggs, Laura L., Mount Desert Island Biological Lab, Salisbury Harbor, Maine, United States
  • Schiffer, Mario, Hannover Medical School, Hannover, Germany
  • Müller-Deile, Janina, MHH, Hanover, Germany
  • Schenk, Heiko Joachim, Hannover Medical School, Hannover, Germany
  • Park, Joon-Keun, Hannover Medical School, Hannover, Germany
  • Haller, Hermann G., Hannover Medical School, Hannover, Germany
Background

The endothelial cell surface is covered by the heparin sulphate proteoglycans (HSPG). Alterations in the level of 6-O-sulfation of the HS chains modulate the binding and release of signaling molecules and affect vascular function. The regulation of the glycocalyx is not well understood. Heparan sulfate 6-O-endosulfatases (sulf1 and -2) regulate the binding properties of the glycocalyx. We tested the hypothesis that 6-O-sulfation is important for glomerular stability and that changes in 6-O-sulfation lead to glomerular damage and albuminuria.

Methods

To assess sulf-1 and -2 function in vivo we used a transgenic zebrafish model (Tg(I-fabp:eGFP-DBP) and measured edema formation and loss of fluorescent protein from the circulation after knock-down of sulf-1 and -2. We further tested whether loss of sulf enhanced glomerular injury in zebrafish using PAN injury. In addition, mice deficient for Sulf-1 and -2 were analyzed. Urinary albumin was measured by ELISA. Immunohistochemistry was performed on cryostat or on paraffin sections.

Results

Loss of Sulf-1 and -2A/B led to a dose-dependent increase in edema formation and albuminuria in zebrafish. Vascular permeability was enhanced after sulf-2 knock down. Reduction of sulfatases enhanced the PAN-induced albuminuria significantly. Vascular patterning was slightly affected by Sulf-2, indicating a role in vascular development of the isoform. In Sulf-2 deficient mice albuminuria occurred after week 4. The glomerular mesangium showed increased proliferation. Glomerular VEGF165 as well as p38 and pERK immunoreactivity were increased.

Conclusion

The level of 6-O-sulfation of HS chains of the glycocalyx is an important determinator of glomerular health and pathophysiology. Our results suggest that Sulf-1 and -2 regulate the signaling properties of VEGF and other growth factors in the renal microcirculation.

Funding

  • Government Support - Non-U.S.